Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 218, pseudogene (RN7SL218P) is a human genomic sequence classified as a pseudogene. It is a truncated and nonfunctional copy of the gene encoding 7SL RNA, which is a core RNA component of the signal recognition particle (SRP). While true 7SL RNA is essential for protein targeting to the endoplasmic reticulum, RN7SL218P lacks coding potential and regulatory elements necessary for functional RNA and has no known biological activity. Pseudogenes like RN7SL218P result from the reverse transcription and integration of RNA sequences back into the genome, but they do not produce active RNA or protein products[1][6][4]. RN7SL218P is not a therapeutic target, nor is it implicated in human disease, does not interact with drugs, and has no established biomarker or safety concern relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 218, pseudogene (RN7SL218P).